{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:39:56Z","timestamp":1793313596304,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"etherlands Organization for Scientific Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.07.032","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T17:52:48Z","timestamp":1597773168000},"page":"6224-6235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of human single nucleotide polymorphisms on Bacillus Calmette-Gu\u00e9rin responses"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8404-4462","authenticated-orcid":false,"given":"Nicole L.","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.07.032_b0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.vaccine.2020.07.032_b0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0962-8479(96)90025-8","article-title":"Does bacille Calmette-Guerin scar size have implications for protection against tuberculosis or leprosy?","volume":"77","author":"Sterne","year":"1996","journal-title":"Tuber Lung Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.032_b0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/597069","article-title":"Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy","volume":"199","author":"Lalor","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.07.032_b0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12916-016-0617-3","article-title":"Human newborn bacille Calmette-Guerin vaccination and risk of tuberculosis disease: a case-control study","volume":"14","author":"Fletcher","year":"2016","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0030","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1038\/s41598-018-31537-9","article-title":"Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination","volume":"8","author":"Hasso-Agopsowicz","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.07.032_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2013.00081","article-title":"Variation between populations in the innate immune response to vaccine adjuvants","volume":"4","author":"Kollmann","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.07.032_b0040","first-page":"65","article-title":"Immunotherapy for bladder cancer","volume":"7","author":"Fuge","year":"2015","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.vaccine.2020.07.032_b0045","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.07.032_b0050","doi-asserted-by":"crossref","unstructured":"Novakovic B, Messina N, Curtis N. The heterologous effects of Bacillus Calmette-Gu\u00e9rin (BCG) vaccine and trained innate immunity, in: Faustman DL, editor. The value of BCG and TNF in autoimmunity, 2nd ed. Academic Press; 2018. p. 71\u201390 [chapter 6].","DOI":"10.1016\/B978-0-12-814603-3.00006-9"},{"issue":"11","key":"10.1016\/j.vaccine.2020.07.032_b0055","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/infdis\/jiy069","article-title":"Neonatal BCG vaccination influences cytokine responses to toll-like receptor ligands and heterologous antigens","volume":"217","author":"Freyne","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.07.032_b0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","article-title":"Variation in the human immune system is largely driven by non-heritable influences","volume":"160","author":"Brodin","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2013.08.041","article-title":"Genetic variants regulating immune cell levels in health and disease","volume":"155","author":"Orru","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.smim.2015.03.003","article-title":"ImmVar project: Insights and design considerations for future studies of \u201chealthy\u201d immune variation","volume":"27","author":"De Jager","year":"2015","journal-title":"Semin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1375\/twin.2.4.250","article-title":"Genetic and environmental causes of variation in basal levels of blood cells","volume":"2","author":"Evans","year":"1999","journal-title":"Twin Res"},{"issue":"11","key":"10.1016\/j.vaccine.2020.07.032_b0090","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1086\/375249","article-title":"Heritability analysis of cytokines as intermediate phenotypes of tuberculosis","volume":"187","author":"Stein","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4269\/ajtmh.12-0670","article-title":"Genetic and shared environmental influences on interferon-gamma production in response to Mycobacterium tuberculosis antigens in a Ugandan population","volume":"89","author":"Tao","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.vaccine.2020.07.032_b0100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.4139","article-title":"Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi","volume":"22","author":"Li","year":"2016","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.032_b0105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.07.032_b0110","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s10096-012-1660-4","article-title":"Association of polymorphism +874 A\/T of interferon-gamma and susceptibility to the development of tuberculosis: meta-analysis","volume":"31","author":"de Albuquerque","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.032_b0115","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.4238\/2015.August.7.21","article-title":"Vitamin D receptor gene FokI, TaqI, BsmI, and ApaI polymorphisms and susceptibility to pulmonary tuberculosis: a meta-analysis","volume":"14","author":"Lee","year":"2015","journal-title":"Genet Mol Res"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0120","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.5114\/aoms.2016.60092","article-title":"Vitamin D receptor gene FokI polymorphisms and tuberculosis susceptibility: a meta-analysis","volume":"12","author":"Cao","year":"2016","journal-title":"Arch Med Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2020.07.032_b0125","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.apjtm.2016.11.006","article-title":"Genetic association study of P2x7 A1513C (rs 3751143) polymorphism and susceptibility to pulmonary tuberculosis: A meta-analysis based on the findings of 11 case-control studies","volume":"9","author":"Alshammari","year":"2016","journal-title":"Asian Pac J Trop Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.humimm.2015.11.009","article-title":"A meta-analysis of P2X7 gene-1513A\/C polymorphism and pulmonary tuberculosis susceptibility","volume":"77","author":"Ge","year":"2016","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01516-16","article-title":"Tuberculosis susceptibility and vaccine protection are independently controlled by host genotype","volume":"7","author":"Smith","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2020.07.032_b0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12863-014-0139-y","article-title":"Identification of single nucleotide polymorphisms in Toll-like receptor candidate genes associated with tuberculosis infection in water buffalo (Bubalus bubalis)","volume":"15","author":"Alfano","year":"2014","journal-title":"BMC Genet"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.032_b0145","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2052.2011.02203.x","article-title":"Polymorphisms of the SLC11A1 gene and resistance to bovine tuberculosis in African Zebu cattle","volume":"42","author":"Kadarmideen","year":"2011","journal-title":"Anim Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212067","article-title":"Variance components for bovine tuberculosis infection and multi-breed genome-wide association analysis using imputed whole genome sequence data","volume":"14","author":"Ring","year":"2019","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/hdy.2013.137","article-title":"Genome-wide association study identifies novel loci associated with resistance to bovine tuberculosis","volume":"112","author":"Bermingham","year":"2014","journal-title":"Heredity (Edinb)"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030545","article-title":"A genome wide association scan of bovine tuberculosis susceptibility in Holstein-Friesian dairy cattle","volume":"7","author":"Finlay","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2020.07.032_b0165","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00432-011-1056-3","article-title":"BCG response prediction with cytokine gene variants and bladder cancer: where we are?","volume":"137","author":"Ahirwar","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0170","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.vaccine.2020.07.032_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002174","article-title":"Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants","volume":"7","author":"Randhawa","year":"2011","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/INF.0000000000001375","article-title":"Association of MBL2, TLR1, TLR2 and TLR6 Polymorphisms With Production of IFN-gamma and IL-12 in BCG Osteitis Survivors R1","volume":"36","author":"Poyhonen","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.032_b0185","first-page":"184","article-title":"Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study","volume":"51","author":"Zodpey","year":"2007","journal-title":"Indian J Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0190","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.ede.0000231546.14749.ab","article-title":"Tuberculin reaction, BCG scar, and lower female mortality","volume":"17","author":"Roth","year":"2006","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.032_b0195","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/cid\/civ452","article-title":"Development of BCG Scar and Subsequent Morbidity and Mortality in Rural Guinea-Bissau","volume":"61","author":"Storgaard","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0377-1237(17)30675-5","article-title":"Tuberculosis in Bcg vaccinated and unvaccinated children","volume":"53","author":"Raman","year":"1997","journal-title":"Med J Armed Forces India"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/INF.0b013e31816099e6","article-title":"Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children","volume":"27","author":"Anuradha","year":"2008","journal-title":"Pediatric Infectious Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tube.2009.11.002","article-title":"Cytokine genes are associated with tuberculin skin test response in a native Brazilian population","volume":"90","author":"Zembrzuski","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"issue":"9","key":"10.1016\/j.vaccine.2020.07.032_b0215","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","article-title":"A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production","volume":"61","author":"Pravica","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2020.07.032_b0220","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/405310","article-title":"Innate immune recognition of Mycobacterium tuberculosis","volume":"2011","author":"Kleinnijenhuis","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.07.032_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208940","article-title":"Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria","volume":"13","author":"Graustein","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.07.032_b0230","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201611-2346OC","article-title":"A Functional TOLLIP variant is associated with BCG-specific immune responses and tuberculosis","author":"Shah","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.micinf.2011.08.018","article-title":"Tollip: a multitasking protein in innate immunity and protein trafficking","volume":"14","author":"Capelluto","year":"2012","journal-title":"Microbes Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/gene.2015.8","article-title":"Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: systematic review and meta-analysis","volume":"16","author":"Archer","year":"2015","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.032_b0245","first-page":"3048","article-title":"Relationship between NRAMP1 gene polymorphism and efficacy of BCG vaccine in a helminth-infected population","volume":"12","author":"Badawy","year":"2013","journal-title":"Genet Mol Res"},{"issue":"10","key":"10.1016\/j.vaccine.2020.07.032_b0250","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.4049\/jimmunol.171.10.5442","article-title":"A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria","volume":"171","author":"Saunders","year":"2003","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0255","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/jbc.M507816200","article-title":"A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages","volume":"281","author":"Shemon","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2020.07.032_b0260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.meegid.2014.03.006","article-title":"The effect of P2X7 receptor 1513 polymorphism on susceptibility to tuberculosis: A meta-analysis","volume":"24","author":"Wu","year":"2014","journal-title":"Infect Genet Evol"},{"issue":"9","key":"10.1016\/j.vaccine.2020.07.032_b0265","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/gtmb.2013.0202","article-title":"Association of P2X7 A1513C (rs3751143) gene polymorphism with risk of tuberculosis: evidence from a meta-analysis","volume":"17","author":"Areeshi","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0270","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1440-1843.2011.01976.x","article-title":"Lack of association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis: a meta-analysis","volume":"16","author":"Wang","year":"2011","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1574-695X.2010.00735.x","article-title":"Metaanalysis of P2X7 gene polymorphisms and tuberculosis susceptibility","volume":"60","author":"Xiao","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0280","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/INF.0b013e3181f43a4e","article-title":"Clinical implication of the C allele of the ITPKC gene SNP rs28493229 in Kawasaki disease: association with disease susceptibility and BCG Scar reactivation","volume":"30","author":"Lin","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0290","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.TP.0000055216.19866.9A","article-title":"Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms","volume":"75","author":"Suarez","year":"2003","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0295","doi-asserted-by":"crossref","first-page":"36","DOI":"10.11613\/BM.2015.004","article-title":"Pathologic patterns of interleukin 10 expression\u2013a review","volume":"25","author":"Trifunovic","year":"2015","journal-title":"Biochem Med (Zagreb)"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0300","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12274","article-title":"T cells and adaptive immunity to Mycobacterium tuberculosis in humans","volume":"264","author":"Jasenosky","year":"2015","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/trstmh\/tru168","article-title":"Trained immunity: consequences for the heterologous effects of BCG vaccination","volume":"109","author":"Kleinnijenhuis","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2020.07.032_b0310","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2020.07.032_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.032_b0320","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/imm.13145","article-title":"The role of Toll-like receptor 10 in modulation of trained immunity","volume":"159","author":"Mourits","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2020.07.032_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.032_b0330","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0335","doi-asserted-by":"crossref","first-page":"12800","DOI":"10.1038\/s41598-017-13017-8","article-title":"An eQTL variant of ZXDC is associated with IFN-gamma production following Mycobacterium tuberculosis antigen-specific stimulation","volume":"7","author":"Jabot-Hanin","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2020.07.032_b0340","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.vaccine.2012.01.053","article-title":"The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda","volume":"30","author":"Anderson","year":"2012","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2020.07.032_b0345","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0350","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.032_b0355","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mt.2015.216","article-title":"Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms","volume":"24","author":"Zhang","year":"2016","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0360","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-3083.2010.02426.x","article-title":"Interferon-gamma +874 T\/A and interleukin-10 -1082 A\/G single nucleotide polymorphism in Egyptian children with tuberculosis","volume":"72","author":"Mosaad","year":"2010","journal-title":"Scand J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2020.07.032_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160149","article-title":"Revisiting the heterogeneous IFN-gamma response of Bacille of Calmette-Guerin (BCG)-revaccinated healthy volunteers in a randomized controlled trial: effect of the body mass index and of the IFNG+874 A\/T polymorphism","volume":"11","author":"Conceicao","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41435-019-0080-1","article-title":"A SNP upstream of the cyclic GMP-AMP synthase (cGAS) gene protects from relapse and extra-pulmonary TB and relates to BCG vaccination status in an Indian cohort","volume":"21","author":"Thada","year":"2020","journal-title":"Genes Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0375","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3349\/ymj.2018.59.1.119","article-title":"ITPKC and SLC11A1 Gene polymorphisms and gene-gene interactions in Korean patients with Kawasaki disease","volume":"59","author":"Kim","year":"2018","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0380","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3855\/jidc.5047","article-title":"Effectiveness of the Bacillus Calmette-Guerin vaccine in an Indonesian population with D543N NRAMP1 polymorphism","volume":"9","author":"Putera","year":"2015","journal-title":"J Infect Develop Countr"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.032_b0385","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2478\/v10042-008-0044-1","article-title":"Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin","volume":"46","author":"Strapagiel","year":"2008","journal-title":"Folia Histochem Cytobiol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0390","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tube.2007.02.001","article-title":"Association of polymorphisms in IL-12\/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia","volume":"87","author":"Sahiratmadja","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"42","key":"10.1016\/j.vaccine.2020.07.032_b0395","doi-asserted-by":"crossref","first-page":"E4478","DOI":"10.1073\/pnas.1410293111","article-title":"Human TLR10 is an anti-inflammatory pattern-recognition receptor","volume":"111","author":"Oosting","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156046","article-title":"TLR1 variant H305L associated with protection from pulmonary tuberculosis","volume":"11","author":"Meyer","year":"2016","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2020.07.032_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003099","article-title":"Pre-miR-146a (rs2910164 G>C) single nucleotide polymorphism is genetically and functionally associated with leprosy","volume":"8","author":"Cezar-de-Mello","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.07.032_b0410","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/gene.2010.14","article-title":"Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion","volume":"11","author":"Shey","year":"2010","journal-title":"Genes Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0415","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apa.12927","article-title":"Toll-like receptor 2 subfamily gene polymorphisms are associated with Bacillus Calmette-Guerin osteitis following newborn vaccination","volume":"104","author":"Poyhonen","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2020.07.032_b0420","article-title":"Toll-like receptor 4 polymorphisms were associated with low serum pro-inflammatory cytokines in BCG osteitis survivors","author":"Korppi","year":"2019","journal-title":"Acta Paediatrica, Int J Paediat"},{"key":"10.1016\/j.vaccine.2020.07.032_b0425","doi-asserted-by":"crossref","DOI":"10.1111\/apa.14000","article-title":"Interleukin 17A gene polymorphism rs2275913 is associated with osteitis after the Bacillus Calmette-Guerin vaccination","author":"Liehu-Martiskainen","year":"2017","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0430","doi-asserted-by":"crossref","first-page":"11691","DOI":"10.1038\/s41598-017-12113-z","article-title":"Haplotype of the Interleukin 17A gene is associated with osteitis after Bacillus Calmette-Guerin vaccination","volume":"7","author":"Korppi","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0435","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13547500902818246","article-title":"Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy","volume":"14","author":"Ahirwar","year":"2009","journal-title":"Biomarkers"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.032_b0440","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bju.12844","article-title":"The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guerin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population","volume":"116","author":"Lima","year":"2015","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0445","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000331882","article-title":"IL-4 and TNF-alpha polymorphisms are associated with risk of multiple superficial tumors or carcinoma in situ development","volume":"87","author":"Lima","year":"2011","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.032_b0450","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2010.11.031","article-title":"NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guerin therapy for bladder cancer","volume":"59","author":"Chiong","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0455","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0022-5347(05)00653-1","article-title":"Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"175","author":"Decobert","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.032_b0460","first-page":"1737","article-title":"Predictive Value of NRAMP1 and HGPX1 Gene Polymorphism for Maintenance BCG Response in Non-muscle-invasive Bladder Cancer","volume":"36","author":"Lenormand","year":"2016","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.032_b0465","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/BLC-150027","article-title":"Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response","volume":"2","author":"Grotenhuis","year":"2016","journal-title":"Bladder Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:48Z","timestamp":1759402008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20309506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":93,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20309506"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of human single nucleotide polymorphisms on Bacillus Calmette-Gu\u00e9rin responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}